Insights & Ideas

We examine whether findings observed in trial-eligible populations remain consistent when the same methods are applied to broader real-world populations.

We explore how modern open-source R workflows can turn reporting specifications into reproducible, executable, and more transparent clinical reporting systems.

We examine how fairness diagnostics can reveal clinically important differences in model performance across patient groups and support more transparent evaluation.

We explore how multiplicity methods can reduce thousands of candidate findings to a smaller set of statistically credible and interpretable signals.

Using NHANES data, we show how uncertainty can be quantified and incorporated into risk estimation rather than treated as a statistical nuisance.

We demonstrate how heterogeneous legacy studies can be harmonized into a common patient-level database suitable for integrated analysis and evidence generation.

We explore how treatment-effect heterogeneity methods move beyond simple subgroup comparisons toward more informative and clinically relevant precision-medicine analyses.